Delivery Order SPE2DB20D3103-SPE2DB23FP3J4
- Not listed
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $29,013.80 firm fixed-price delivery order covers the supply of 4,560,376,093 units of the pharmaceutical drug Ondansetron ODT 4 mg Tablet in 30-count packages. The contract has an ultimate completion date of March 27, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,361.64 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,789,214 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of February 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026....
- This federal contract award, valued at $10,725.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,778,520 units of Ondansetron ODT 4 mg tablets. This contract award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,500.96 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4559291100 - Ondansetron ODT 4 mg Tablets. This delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,092.97 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary...
- The federal contract award SPE2DB20D3111|SPE2DB24FA7NU was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,953.32 firm fixed-price delivery order is for the supply of 4,564,478,692 Ondansetron ODT 4 mg tablets, with an ultimate completion date of May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop...
- This federal contract award, valued at $35,886.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562985541 - Ondansetron ODT 4 MG Tablet 30S, a pharmaceutical product, with a completion date of December 5, 2023. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,560,616,544 units of Ondansetron ODT 4 mg tablets in 30-count packages. The award has a ceiling value of $1,902.33 and an ultimate completion date of April 18, 2023. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,245.96 firm fixed-price delivery order is for 4,564,413,840 units of the medication Ondansetron ODT 4 mg tablet. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc. valued at up to $999,999,999.00, which serves as...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,816.93 delivery order is for the supply of Ondansetron ODT 4 mg tablets, with a completion date of September 21, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP3J4Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver 4,561,783,106 units of Ondansetron ODT 4 mg tablets. The $4,427.20 firm-fixed-price delivery order has an ultimate completion date of August 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These contracts demonstrate Cencora, Inc.'s extensive capabilities in delivering essential pharmaceutical and medical commodities to various federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/11/23 |